![Sung-Hwan Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 482 024 $ au 30/06/2026
Sung-Hwan Kim currently works at Voronoi, Inc., as Executive Board Member & Head-Bio Research.
Dr. Kim received his doctorate degree from the University of Utah, undergraduate degree from Kyungpook National University, and graduate degree from Gwangju University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VORONOI, INC. 0,02% | 15/06/2026 | 4 000 ( 0,02% ) | 482 024 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VORONOI, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyungpook National University
 Kyungpook National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gwangju University
 Gwangju University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voronoi, Inc.
 Voronoi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures novel kinase inhibitors and target protein degrader drugs | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
